MassMEDIC Archives - Medical Design Sourcing

MassMEDIC makes changes to its board and executive committee

The Massachusetts Medical Device Industry Council (MassMEDIC) announced today the replacement of three board members and a new executive committee roster.

Joining the board are Zoll Resuscitation President Elijah White, Olympus Corp. of America SVP and Global Head of Business Development Townsend Goddard, and Cambridge Consultants SVP and Head of Medtech (U.S. West) Nick Hawson.

They replace retiring board members Christos Monovoukas (former VP of global business development at Olympus Corp. of America), David Bradshaw (senior assessment services manager at Cambridge Consultants), and Jon Rennert (CEO of Zoll Medical), who served as the board’s chair from 2017-2020.

“On behalf of the MassMEDIC community, we are excited to welcome our new Board members and thank those who are transitioning off for their service and dedication,” MassMEDIC President Brian Johnson said in a news release. “We want to extend a special thank you to Jon Rennert f…

MassMEDIC Ignite alumni break $100M funding milestone

Embr Labs makes the wearable Wave device for cooling relief from menopausal hot flashes. [Image courtesy of Embr Labs]CoreMap’s $23 million in recently closed funding officially puts MassMEDIC’s Ignite alumni from the past three years over the $100 million mark, the medtech accelerator said.

Fifty medtech startups have participated in MassMEDIC’s Ignite since the program relaunched in 2019. The program matches startup founders with mentors in leadership positions at New England medtech organizations, makes introductions to investors and offers networking and experiential training to boost the region’s industry.

Get the full story at our sister site, Medical Design & Outsourcing.

MassMEDIC Ignite alumni break $100M funding milestone

Embr Labs makes the wearable Wave device for cooling relief from menopausal hot flashes. [Image courtesy of Embr Labs]

CoreMap’s $23 million in recently closed funding officially puts MassMEDIC’s Ignite alumni from the past three years over the $100 million mark, the medtech accelerator said.

Fifty medtech startups have participated in MassMEDIC’s Ignite since the program relaunched in 2019. The program matches startup founders with mentors in leadership positions at New England medtech organizations, makes introductions to investors and offers networking and experiential training to boost the region’s industry.

“The experience of the program, the network of contacts and the MassMEDIC community of support continues to be of great value to us,” Sarah Kalil, co-founder and CEO of Burlington, Vermont–based CoreMap, said in a news release.

CoreMap leads all Ignite alumni …

CoreMap raises $23 million to fund AFib mapping development

Sarah Kalil is CEO and co-founder of CoreMap. [Photo courtesy of CoreMap]

CoreMap today announced it closed a $20 million Series B financing to accelerate the development of its cardiac arrhythmia diagnostic technology and launch pilot studies.

The Burlington, Vermont–based company said it also closed on a $3 million Series A Milestone financing that was part of its $10.5 million Series A in September 2020. In addition, CoreMap won a National Science Foundation research grant that same month after participating as one of the startups in MassMEDIC’s IGNITE virtual accelerator when the program relaunched in 2019.

CoreMap said pre-clinical and clinical studies have successfully demonstrated the CoreMap System, which consists of the company’s high-resolution Invenio catheter and VidereX workstation.

“We have a catheter that will go inside the heart to record the electrical activity with hi…

MassMEDIC announces board additions

The Massachusetts Medical Device Industry Council (MassMEDIC) today announced the appointment of eight new members to its board of directors.

Joseph Ferrara, Michelle Fox, Brent Fullerton, Chris Killburn-Peterson, Jaydeo Kinikar, Sonal Patel, Stacey Pugh and Adam Sachs have all joined the MassMEDIC board.

“We are honored to welcome our new members to our Board of Directors to further the mission of saving and improving the lives of patients everywhere through medical technology,” MassMEDIC President Brian Johnson said in a news release. “Their dedication to continuous improvement of our healthcare ecosystem in Massachusetts and New England, paired with their industry expertise, will strengthen our community built on collaboration and collaborative success.”

Ferrara serves as chief innovation officer at Veranex and holds more than 25 years of experience in the medtech industry. Fox, who is CMO at Teleflex, offers vast experience in clinical affairs and…

MassMEDIC announces 2021 Ignite accelerator winners

MassMEDIC announced today that it concluded its 2021 MedTech IGNITE accelerator program for medical device companies.

Boston-based MassMEDIC (the Massachusetts Medical Device Industry Council) had 12 startups in the 2021 IGNITE cohort, with the companies including developers of wearables, diagnostics and surgical devices across areas such as women’s health, neurology, oncology, infectious disease, diabetes and cardiology.

Get the full story at our sister site, Medical Design & Outsourcing.

MassMEDIC announces 2021 Ignite accelerator winners

MassMEDIC announced today that it concluded its 2021 MedTech IGNITE accelerator program for medical device companies.

Boston-based MassMEDIC (the Massachusetts Medical Device Industry Council) had 12 startups in the 2021 IGNITE cohort, with the companies including developers of wearables, diagnostics and surgical devices across areas such as women’s health, neurology, oncology, infectious disease, diabetes and cardiology.

The IGNITE cohort participated in virtual classes run by medtech executives with expertise in a number of areas, while it also included virtual networking events and fireside chats with industry luminaries. Participating startups also worked on pitches with feedback from VCs and experienced mentors.

Winners were selected by their peers, with each cohort founder presenting their corporate pitch to the cohort. They were scored on product market fit, business plan and team strength.

Encora Therapeutics won the competition, bri…

An even larger medtech supply chain shock looms beyond the pandemic

[Image via Pixabay] Superstorms, fires, droughts and other extreme events driven by climate change are already straining the industry’s supply chain — and it could get a lot worse.

Drifting wildfire smoke made for blazing sunrises and sunsets this summer in Minnesota, where electronics manufacturer Nortech Systems has been replacing air handling equipment to ensure particle filtration and the ability to operate in more extreme temperatures.

“I had days where I jumped in the car, and I drove up to Bemidji and [the smoke] got steadily worse,” CEO Jay Miller said. “I’m thinking about not only small particles of particulate matter in very sensitive boards that we’re manufacturing, I’m also thinking about my employees that have asthma. … I can put them in a good environment for eight hours a day, but how are they going to be the rest of the time? That’s worrisome.”

Medical device companies are increasingly focusing on the risk climate change poses to their businesse…

MassMedic: New England suited to be drug delivery device powerhouse

The Massachusetts Medical Device Industry Council (MassMedic) believes New England is capable of growing in the drug delivery device space.

In a recently published report written by Alira Health’s Aude Ouesanga, Laure Girard and Marie Vaillant and shared by MassMedic, a shift in the space was highlighted in terms of devices enabling therapeutic delivery to actually having an impact on the performance of the drug. The addition of connectivity capabilities in digital health ecosystems offers more in terms of monitoring and data collection, too.

Get the full story at our sister site, Drug Delivery Business News.

How the presidential election could affect medtech

No matter who ends up in the White House, there will need to be a reckoning over how the government’s relationship with medtech has changed, according to industry insiders.

(Image by Markus Winkler on Unsplash)

It’s been a tumultuous few years for the medical device industry, with highs and lows that no one could have foreseen.

President Donald Trump’s administration streamlined some FDA processes. The medical device excise tax, enacted during the Obama-Biden administration, was permanently repealed.

But any normal state of affairs in the industry was upended by the coronavirus pandemic. COVID-19 disrupted supply chains, brought elective surgeries to a halt and attracted all sorts of businesses to jump into an industry that they knew nothing about. The pandemic also brought about unprecedented cooperation within medtech and betw…